MIR5580

Across TCGA pan-cancer cohorts, MIR5580 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR5580 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR5580 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR5580 expression acts as an unfavorable survival marker, although some lineages such as STAD and LGG show a favorable association.

STAD, THYM, and LUAD are the cancer types where MIR5580 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.829	0.503	<.001	117	view →
THYM	OS	Tertile	All	0.534	0.968	<.001	72	view →
LUAD	OS	Tertile	III,IV	0.056	0.672	<.001	54	view →
LIHC	OS	Tertile	II,III,IV	0.182	0.627	<.001	54	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
LGG	DFS	Tertile	All	0.758	0.376	.007	15	view →
THCA	OS	Tertile	All	0.944	0.983	.011	12	view →
COAD	OS	Tertile	IV	0.228	0.578	.044	9	view →
PRAD	OS	Tertile	All	0.942	0.996	.047	6	view →
ACC	OS	Tertile	III,IV	0.508	0.832	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR5580–STAD (OS)

Open the STAD breakdown →